Biomuxol

Biomuxol (also referred to as Biomucol in some contexts) is a respiratory medication developed and marketed by Laboratorios Mallén. It is formulated as an oral solution containing acefylline (also known as acebroline) at a concentration of 50 mg/5 mL. The drug serves a dual therapeutic role as a bronchodilator and mucoregulator, making it suitable for managing respiratory conditions involving airway constriction and mucus congestion. As a xanthine derivative, its mechanism of action involves the inhibition of phosphodiesterase enzymes and the antagonism of adenosine receptors, which together promote bronchial smooth muscle relaxation and improve mucociliary clearance.

Brand names

BiomuxolBiomucol

Other names

acefyllineacebrolineacefylline piperazine